Subtopic Deep Dive
Cancer Clinical Trials During Pandemics
Research Guide
What is Cancer Clinical Trials During Pandemics?
Cancer Clinical Trials During Pandemics examines adaptations in trial enrollment, protocols, and remote conduct for cancer patients amid disruptions like COVID-19.
COVID-19 caused enrollment drops of up to 80% in cancer trials due to lockdowns and safety concerns (Richards et al., 2020). Protocol adaptations included telemedicine and remote monitoring to maintain data integrity (Anthony, 2020; Doraiswamy et al., 2020). Over 50 papers document these shifts, with Kuderer et al. (2020) cited 1776 times for cohort impacts.
Why It Matters
Sustaining cancer trials during pandemics prevents delays in therapy innovation, as seen in global elective surgery cancellations modeled by Al-Sheikh Ali (2020, 1433 citations). Telemedicine enabled remote care, reducing infection risks for immunocompromised patients (Fung and Babik, 2020; Anthony, 2020). Richards et al. (2020) highlight care disruptions affecting millions, underscoring regulatory adaptations for trial continuity.
Key Research Challenges
Enrollment Declines
Pandemic lockdowns reduced cancer trial enrollment by 70-80%, prioritizing acute COVID care (Richards et al., 2020). Patients avoided sites due to infection fears, especially immunocompromised ones (Kuderer et al., 2020). Recovery models predict long-term backlogs (Al-Sheikh Ali, 2020).
Data Integrity Risks
Remote adaptations raised concerns over protocol deviations and missing data in cancer cohorts (Yang et al., 2020). Multicenter studies in Wuhan showed higher severity in cancer patients, complicating outcome tracking (Tian et al., 2020). Verification methods were needed for virtual endpoints.
Regulatory Adaptations
FDA and EMA issued emergency guidelines for trial modifications, but implementation varied globally (Richards et al., 2020). Balancing speed with safety challenged trial integrity during peak disruptions (Nepogodiev et al., 2020). Harmonizing international standards remains unresolved.
Essential Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · 2020 · The Lancet · 1.8K citations
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
Dmitri Nepogodiev, Aneel Bhangu, James Glasbey et al. · 2020 · The Lancet · 1.7K citations
Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans
Zaid Al-Sheikh Ali · 2020 · British journal of surgery · 1.4K citations
BACKGROUND: The COVID-19 pandemic has disrupted routine hospital services globally. This study estimated the total number of adult elective operations that would be cancelled worldwide during the 1...
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
Khanh Bao Tran, Justin J. Lang, Kelly Compton et al. · 2022 · The Lancet · 868 citations
Use of Telemedicine and Virtual Care for Remote Treatment in Response to COVID-19 Pandemic
Bokolo Anthony · 2020 · Journal of Medical Systems · 808 citations
Abstract The current coronavirus disease 2019 (COVID-19) pandemic has caused significant strain on medical centers resources. Thus, concerns about the reducing and management of COVID-19 are on the...
Use of Telehealth During the COVID-19 Pandemic: Scoping Review
Sathyanarayanan Doraiswamy, Amit Abraham, Ravinder Mamtani et al. · 2020 · Journal of Medical Internet Research · 707 citations
Background With over 37.8 million cases and over 1 million deaths worldwide, the COVID-19 pandemic has created a societal and economic upheaval of unparalleled magnitude. A positive transformation ...
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
Kunyu Yang, Yuhan Sheng, Chaolin Huang et al. · 2020 · The Lancet Oncology · 591 citations
Reading Guide
Foundational Papers
No pre-2015 foundational papers available; start with highest-cited COVID-era works: Kuderer et al. (2020) for cohort baselines and Richards et al. (2020) for systemic impacts.
Recent Advances
Study Al-Sheikh Ali (2020) for recovery modeling and Anthony (2020) for telemedicine advances, both with 1400+ and 800+ citations.
Core Methods
Cohort studies (Kuderer et al., 2020; Tian et al., 2020), predictive modeling (Al-Sheikh Ali, 2020), and telehealth scoping reviews (Doraiswamy et al., 2020).
How PapersFlow Helps You Research Cancer Clinical Trials During Pandemics
Discover & Search
Research Agent uses searchPapers and exaSearch to find 50+ papers on trial adaptations, starting with Kuderer et al. (2020). citationGraph reveals impact networks from Richards et al. (2020) to telehealth studies like Anthony (2020). findSimilarPapers expands to cohort analyses like Yang et al. (2020).
Analyze & Verify
Analysis Agent employs readPaperContent on Kuderer et al. (2020) abstracts to extract enrollment stats, then verifyResponse with CoVe checks claims against Tian et al. (2020). runPythonAnalysis processes citation data via pandas for trend plots, with GRADE grading for evidence strength in pandemic cohorts.
Synthesize & Write
Synthesis Agent detects gaps in remote trial data via contradiction flagging between Richards et al. (2020) and Doraiswamy et al. (2020). Writing Agent uses latexEditText, latexSyncCitations for trial adaptation reviews, and latexCompile for manuscripts with exportMermaid diagrams of protocol flows.
Use Cases
"Extract enrollment drop stats from COVID cancer trial papers and plot trends"
Research Agent → searchPapers → Analysis Agent → readPaperContent (Kuderer et al., 2020; Richards et al., 2020) → runPythonAnalysis (pandas plot of 1776-citation impacts) → matplotlib trend graph output.
"Write LaTeX review on telemedicine in cancer trials during COVID"
Synthesis Agent → gap detection → Writing Agent → latexEditText (draft from Anthony 2020) → latexSyncCitations (Doraiswamy et al., 2020) → latexCompile → PDF with trial adaptation diagram.
"Find code for modeling pandemic trial disruptions"
Research Agent → searchPapers (Al-Sheikh Ali 2020) → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis on recovery models → statistical forecast output.
Automated Workflows
Deep Research workflow conducts systematic reviews of 50+ papers like Kuderer et al. (2020), generating structured reports on enrollment impacts. DeepScan applies 7-step analysis with CoVe checkpoints to verify data integrity claims from Tian et al. (2020). Theorizer builds hypotheses on telehealth scalability from Anthony (2020) and Doraiswamy et al. (2020).
Frequently Asked Questions
What defines Cancer Clinical Trials During Pandemics?
It covers enrollment drops, protocol changes, and remote methods for cancer trials amid COVID-19 disruptions like those in Kuderer et al. (2020).
What methods addressed trial disruptions?
Telemedicine and virtual monitoring were key, as in Anthony (2020) and Doraiswamy et al. (2020), with regulatory adaptations per Richards et al. (2020).
What are key papers?
Kuderer et al. (2020, 1776 citations) on cancer patient impacts; Richards et al. (2020) on care disruptions; Al-Sheikh Ali (2020, 1433 citations) on surgery cancellations.
What open problems persist?
Long-term data integrity in remote trials and global regulatory harmonization remain challenges, as noted in Yang et al. (2020) and Tian et al. (2020).
Research COVID-19 and healthcare impacts with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cancer Clinical Trials During Pandemics with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the COVID-19 and healthcare impacts Research Guide